| Innovation Title | Categories | Lead Inventor | |
|---|---|---|---|
|
Novel Adenylyl Cyclase 1 Inhibitors for Treatment of Chronic Pain
2020-FLAH-68825 |
Flaherty, Daniel P P. | ||
|
Non-Opioid for Treating Chronic Pain and Opioid Dependence
2017-WATT-67867 |
Watts, Val J | ||
|
Novel Adenylyl Cyclase 1 Inhibitors for Chronic Pain and Opioid Dependence
2017-WATT-67991 |
Watts, Val J | ||
|
Simultaneous Treatment of Alcohol Use and Psychiatric Disorders
2017-VANR-67884 |
van Rijn, Richard M | ||
|
Dr. Richard M. van Rijn is an Assistant Professor of Medicinal Chemistry and Molecular Pharmacology at Purdue University. He earned a B.S. and M.S. in Biopharmaceutical Sciences at Leiden University, Leiden, Netherlands, and a Ph.D. in Molecular Pharmacology from Vrije Universiteit Amsterdam. Dr. van Rijn's research focuses on understanding the development of drug dependence, long-term effects of chronic drug abuse on neuropharmacology, and the effect that neurological disorders have on the progression of drug dependence. His goal is to develop new pharmaceuticals that may assist in treating drug dependence. Current research projects include investigation into the risk of alcohol mixed energy drinks, the role of beta-arrestin dependent signaling in depression and anxiety disorders, the physiological function of opioid-dopamine interactions, and alcohol withdrawal-induced hyperalgesia. For additional information, visit Dr. Van Rijn's Purdue website: http://www.mcmp.purdue.edu/faculty/?uid=rvanrijn or his Van Rijn Lab website: http://www.vanrijnlab.com/ |
|